# First in Human Study to Assess an Implant to Treat Severe Emphysema

> **NCT05854550** · NA · COMPLETED · sponsor: **Apreo Health, Inc.** · enrollment: 48 (actual)

## Conditions studied

- Emphysema or COPD

## Interventions

- **DEVICE:** Apreo Implant Group

## Key facts

- **NCT ID:** NCT05854550
- **Lead sponsor:** Apreo Health, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-05-05
- **Primary completion:** 2024-10-08
- **Final completion:** 2026-02-16
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2026-03-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05854550

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05854550, "First in Human Study to Assess an Implant to Treat Severe Emphysema". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT05854550. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*